Natus Medical Story

Natus Medical Incorporated -- USA Stock  

USD 32.80  2.75  7.74%

Macroaxis does not monitor all media channels or aggregates social signals for Natus Medical. But even though we do not provide professional-grade financial sentiment analysis on Natus Medical Incorp, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Natus Medical. Check also Natus Medical Hype Analysis, Natus Medical Correlation and Natus Medical Performance
Sale by Robert Gunst of 4400 shares of Natus Medical
Filed transaction by Natus Medical Inc director. General open market or private sale of non-derivative or derivative security

Natus Medical Incorporated insider trading alert for sale of common stock $0.001 par value per share by Robert Gunst, the corporate stakeholder, on September 15, 2017. This event was filed by Natus Medical Inc with SEC on 2017-09-15. Statement of changes in beneficial ownership - SEC Form 4. Robert Gunst is currently serves as independent chairman of the board of Natus Medical Incorp

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on September 15, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 0.43% . The trading delta at closing time when the story was published against the current closing price is 3.56% .

Similar stores for Natus Medical

Analyst Research Roundup Natus Medical Incorporated , Signature Banknews
Analyst JournalFull coverage
over a month ago at 
Dana Investment Advisors Lifted Holding in Natus Medical Del by 385133 First Tr Enhanced Eqty FFA ...
BZ WeeklyHow Analysts Rated Natus Medical Incorporated Last Week WeeklyHubNatus Medical Inc to Post FY2018 Earnings of 1.63 Per Share, William Blair Forecasts registrarjournal.comFull coverage
over two months ago at 
Pier Capital Lifted Silicon Laboratories Holding by 1.06 Million As ...
Pier Capital Llc increased its stake in Silicon Laboratories Inc by 17.42 percent based on its latest 2017Q3 regulatory filing with the SEC.
over three months ago at 
40 North Management Has Cut By 93.15 Million Its Cadence Design System Stake Natus Medical BABY ...
Bibeypost.com7 Breakout Stocks for 2018 Zacks.comSEC FORM 4 - SEC.govCDNS Stocks Latest Headlines for Cadence Design Sys - Barchart.comFull coverage

Did you try this?

Run Financial Widgets Now

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Hide  View All  NextLaunch Financial Widgets

Gross Profit

Gross Profit Comparative Analysis
  Gross Profit 
      Natus Medical Comparables 
Natus Medical is currently under evaluation in gross profit category among related companies. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.